Cerner Co. (NASDAQ:CERN) – Stock analysts at William Blair upped their Q1 2020 EPS estimates for Cerner in a report released on Tuesday, April 9th, Zacks Investment Research reports. William Blair analyst J. Garro now anticipates that the company will earn $0.64 per share for the quarter, up from their previous estimate of $0.62. William Blair also issued estimates for Cerner’s Q2 2020 earnings at $0.69 EPS, Q3 2020 earnings at $0.73 EPS, Q4 2020 earnings at $0.80 EPS and FY2020 earnings at $2.86 EPS.
Cerner (NASDAQ:CERN) last posted its quarterly earnings results on Tuesday, February 5th. The company reported $0.63 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.57 by $0.06. The business had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.39 billion. Cerner had a net margin of 11.74% and a return on equity of 14.84%. The company’s revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.58 earnings per share.
CERN has been the subject of a number of other research reports. Zacks Investment Research lowered shares of Cerner from a “hold” rating to a “sell” rating in a research report on Thursday, February 21st. Barclays reissued a “hold” rating and issued a $68.00 target price on shares of Cerner in a research note on Wednesday, April 10th. Citigroup set a $77.00 target price on shares of Cerner and gave the company a “buy” rating in a research note on Wednesday, April 10th. BidaskClub downgraded shares of Cerner from a “hold” rating to a “sell” rating in a research note on Tuesday, January 22nd. Finally, Morgan Stanley downgraded shares of Cerner from an “equal weight” rating to an “underweight” rating and reduced their target price for the company from $68.00 to $47.00 in a research note on Thursday, February 28th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $68.67.
Shares of CERN traded down $0.37 during mid-day trading on Wednesday, reaching $62.68. The stock had a trading volume of 5,349 shares, compared to its average volume of 2,525,299. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.41 and a quick ratio of 2.38. Cerner has a 12 month low of $48.78 and a 12 month high of $67.57. The firm has a market cap of $20.39 billion, a P/E ratio of 28.38, a PEG ratio of 1.98 and a beta of 0.97.
A number of institutional investors have recently modified their holdings of the business. Meeder Asset Management Inc. boosted its stake in Cerner by 7.0% in the 1st quarter. Meeder Asset Management Inc. now owns 68,130 shares of the company’s stock worth $3,898,000 after buying an additional 4,464 shares during the last quarter. BTIM Corp. raised its position in Cerner by 53.5% in the 1st quarter. BTIM Corp. now owns 101,100 shares of the company’s stock worth $5,783,000 after purchasing an additional 35,250 shares during the period. Confluence Investment Management LLC purchased a new position in Cerner in the 1st quarter worth $26,070,000. Pratt Collard Advisory Partners LLC purchased a new position in Cerner in the 1st quarter worth $217,000. Finally, Pennsylvania Trust Co purchased a new position in Cerner in the 1st quarter worth $1,651,000. Institutional investors own 80.81% of the company’s stock.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Read More: What is a Candlestick Chart?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.